A video retinal imaging device, from Epipole, has raised £1.5 million in funding to market its solution.
The patented technology enables clinicians to scan the retina using real-time video and then extract high quality images for further examination. The small, hand held device, is said to be ideal for diseases such as diabetic retinopathy and can act as a general purpose retinal video camera.
The device is being used as part of a THET (Tropical Health and Education Trust) project in Uganda to screen for diabetic retinopathy. The device was selected for the work in Uganda because it is specifically tuned for diabetic retinopathy and has been designed to show vasculature in high contrast.
The recent funding round was led by new investor Greenwood Way Capital with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also participating.
Dr Craig Robertson, founder and CEO of Epipole, said: “We’ve worked with ophthalmologists to test and refine features and capabilities, and will use this funding to implement the key changes needed.”
“We will have a particular focus on the US primary care optometry and ophthalmology markets, and plan to have product available by early 2021.”
Ian Stevens, chairman, said: “There is a tremendous opportunity for handheld and truly portable fundus cameras that are easy to use and combine high quality imaging with attractive pricing.”
“I am delighted to join the company and look forward to working with Craig and his team as we seek to transform ophthalmic imaging with our new technology.”
